Compass Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Compass Therapeutics generated cash of -$19,666,000, which is more than the previous year. Cash used in financing activities reached the amount of $118,611,000 last year. Net change in cash is therefore $97,175,000.
Cash Flow
| 2018 | -33.67M | -2.02M | 64.03M |
|---|---|---|---|
| 2020 | -26.80M | 38K | 48.53M |
| 2021 | -19.66M | -1.77M | 118.61M |
CMPX Cash Flow Statement (2018 – 2021)
| 2021 | 2020 | 2018 | |
|---|---|---|---|
Cash at beginning of period | 47.33M | 25.56M | 29.44M |
Operating activities | |||
Net income | -82.18M | -29.5M | -38.28M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 1.62M | 2.40M | 1.92M |
Stock-based compensation expense | 4.02M | 4.01M | 656K |
| Deferred income tax benefit | 4.02M | 4.01M | 656K |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 |
Accounts payable | -194K | 432K | 992K |
Cash generated by operating activities | -19.66M | -26.80M | -33.67M |
Investing activities | |||
Purchases Of Investments | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.56M | -106K | -2.02M |
Acquisitions Net | 116K | 144K | 0 |
Cash generated by investing activities | -1.77M | 38K | -2.02M |
Financing activities | |||
Common Stock Issued | 128.26M | 60.48M | 0 |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | -9.37M | -5.62M | 0 |
Cash used in financing activities | 118.61M | 48.53M | 64.03M |
Net Change In Cash | 97.17M | 21.77M | 28.33M |
Cash at end of period | 144.51M | 47.33M | 57.77M |
| Data source | Data source |